Recently, several mechanisms have been proposed for the development of castration-resistant prostate cancer(3,4)including mutation, amplification(4,5), expression alternative-splice variants of the androgen receptor(6), or the increase of natural testosterone biosynthesis by cancer cells. The gene discussed is AR; the disease is prostate carcinoma.